Search results for: Mahammed Nadir

Authors: Caixia Gao, Chuanrong Li, Lingli Tang, Lingling Ma, Yonggang Qian, Ning Wang

Abstract:

Knowledge of land surface temperature (LST) is of crucial important in energy balance studies and environment modeling. Satellite thermal infrared (TIR) imagery is the primary source for retrieving LST at the regional and global scales. Due to the combination of atmosphere and land surface of received radiance by TIR sensors, atmospheric effect correction has to be performed to remove the atmospheric transmittance and upwelling radiance. Spinning Enhanced Visible and Infrared Imager (SEVIRI) onboard Meteosat Second Generation (MSG) provides measurements every 15 minutes in 12 spectral channels covering from visible to infrared spectrum at fixed view angles with 3km pixel size at nadir, offering new and unique capabilities for LST, LSE measurements. However, due to its high temporal resolution, the atmosphere correction could not be performed with radiosonde profiles or reanalysis data since these profiles are not available at all SEVIRI TIR image acquisition times. To solve this problem, a two-part six-parameter semi-empirical diurnal temperature cycle (DTC) model has been applied to the temporal interpolation of ECMWF reanalysis data. Due to the fact that the DTC model is underdetermined with ECMWF data at four synoptic times (UTC times: 00:00, 06:00, 12:00, 18:00) in one day for each location, some approaches are adopted in this study. It is well known that the atmospheric transmittance and upwelling radiance has a relationship with water vapour content (WVC). With the aid of simulated data, the relationship could be determined under each viewing zenith angle for each SEVIRI TIR channel. Thus, the atmospheric transmittance and upwelling radiance are preliminary removed with the aid of instantaneous WVC, which is retrieved from the brightness temperature in the SEVIRI channels 5, 9 and 10, and a group of the brightness temperatures for surface leaving radiance (Tg) are acquired. Subsequently, a group of the six parameters of the DTC model is fitted with these Tg by a Levenberg-Marquardt least squares algorithm (denoted as DTC model 1). Although the retrieval error of WVC and the approximate relationships between WVC and atmospheric parameters would induce some uncertainties, this would not significantly affect the determination of the three parameters, td, ts and β (β is the angular frequency, td is the time where the Tg reaches its maximum, ts is the starting time of attenuation) in DTC model. Furthermore, due to the large fluctuation in temperature and the inaccuracy of the DTC model around sunrise, SEVIRI measurements from two hours before sunrise to two hours after sunrise are excluded. With the knowledge of td , ts, and β, a new DTC model (denoted as DTC model 2) is accurately fitted again with these Tg at UTC times: 05:57, 11:57, 17:57 and 23:57, which is atmospherically corrected with ECMWF data. And then a new group of the six parameters of the DTC model is generated and subsequently, the Tg at any given times are acquired. Finally, this method is applied to SEVIRI data in channel 9 successfully. The result shows that the proposed method could be performed reasonably without assumption and the Tg derived with the improved method is much more consistent with that from radiosonde measurements.

Keywords: atmosphere correction, diurnal temperature cycle model, land surface temperature, SEVIRI

Procedia PDF Downloads 247

Authors: Briohny H. Spencer, Russ Chess-Williams, Catherine McDermott, Shailendra Anoopkumar-Dukie, David Christie

Abstract:

Background: Prostate cancer is the second most common cancer diagnosed in men worldwide and the most prevalent in Australian men. In 2015, it was estimated that approximately 18,000 new cases of prostate cancer were diagnosed in Australia. Currently, for localised disease, androgen depravation therapy (ADT) and radiotherapy are a major part of the curative management of prostate cancer. ADT acts to reduce the levels of circulating androgens, primarily testosterone and the locally produced androgen, dihydrotestosterone (DHT), or by preventing the subsequent activation of the androgen receptor. Thus, the growth of the cancerous cells can be reduced or ceased. Radiation techniques such as brachytherapy (radiation delivered directly to the prostate by transperineal implant) or external beam radiation therapy (exposure to a sufficient dose of radiation aimed at eradicating malignant cells) are also common techniques used in the treatment of this condition. Radiotherapy (RT) has significant limitations, including reduced effectiveness in treating malignant cells present in hypoxic microenvironments leading to radio-resistance and poor clinical outcomes and also the significant side effects for the patients. Alpha1-adrenoceptor antagonists are used for many prostate cancer patients to control lower urinary tract symptoms, due to the progression of the disease itself or may arise as an adverse effect of the radiotherapy treatment. In Australia, a significant number (not a majority) of patients receive a α1-ADR antagonist and four drugs are available including prazosin, terazosin, alfuzosin and tamsulosin. There is currently limited published data on the effects of α1-ADR antagonists during radiotherapy, but it suggests these medications may improve patient outcomes by enhancing the effect of radiotherapy. Aim: To determine the impact of α1-ADR antagonists treatments on time to biochemical relapse following radiotherapy. Methods: A retrospective study of male patients receiving radiotherapy for biopsy-proven localised prostate cancer was undertaken to compare cancer outcomes for drug-naïve patients and those receiving α1-ADR antagonist treatments. Ethical approval for the collection of data at Genesis CancerCare QLD was obtained and biochemical relapse (defined by a PSA rise of >2ng/mL above the nadir) was recorded in months. Rates of biochemical relapse, prostate specific antigen doubling time (PSADT) and Kaplan-Meier survival curves were also compared. Treatment groups were those receiving α1-ADR antagonists treatment before or concurrent with their radiotherapy. Data was statistically analysed using One-way ANOVA and results expressed as mean ± standard deviation. Major findings: The mean time to biochemical relapse for tamsulosin, prazosin, alfuzosin and controls were 45.3±17.4 (n=36), 41.5±19.6 (n=11), 29.3±6.02 (n=6) and 36.5±17.6 (n=16) months respectively. Tamsulosin, prazosin but not alfuzosin delayed time to biochemical relapse although the differences were not statistically significant. Conclusion: Preliminary data for the prior and/or concurrent use of tamsulosin and prazosin showed a positive trend in delaying time to biochemical relapse although no statistical significance was shown. Larger clinical studies are indicated and with thousands of patient records yet to be analysed, it may determine if there is a significant effect of these drugs on control of prostate cancer.

Keywords: alpha1-adrenoceptor antagonists, biochemical relapse, prostate cancer, radiotherapy

Procedia PDF Downloads 342